Cost Minimization Analysis of Peg-L-Asparginase Versus E.Coli L-Asparaginase in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients- A Jordanian Perspective
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2148
https://www.valueinhealthjournal.com/article/S1098-3015(16)33514-8/fulltext
Title :
Cost Minimization Analysis of Peg-L-Asparginase Versus E.Coli L-Asparaginase in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients- A Jordanian Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33514-8&doi=10.1016/j.jval.2016.09.2148
First page :
A721
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2036